MurphyHR, BellR, CartwrightC, CurnowP, MareshM, MorganM, et al.Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia, 2017; 60: 1668–1677.
2.
StewartZA, WilinskaME, HartnellS, TempleRC, RaymanG, StanleyKP, et al.Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med, 2016; 375: 644–654.
3.
FarringtonC, StewartZA, BarnardK, HovorkaR, MurphyHR. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes. Diabet Med, 2017; 34: 1461–1469.
4.
LawGR, GilthorpeMS, SecherAL, TempleR, BilousR, MathiesenER, et al.Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes. Diabetologia, 2017; 60: 618–624.
5.
AbellSK, SuenM, PeaseA, BoyleJA, SoldatosG, ReganJ, et al.Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: cohort study. Diabetes Technol Ther, 2017; 19: 280–287.
6.
International Weight Management in Pregnancy Collaborative Group. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials. BMJ, 2017; 358: j3119.
7.
HodsonK, Dalla ManC, SmithFE, BarnesA, McParlinC, CobelliC, et al.Liver triacylglycerol content and gestational diabetes: effects of moderate energy restriction. Diabetologia, 2017; 60: 306–313.
8.
NachumZ, ZafranN, SalimR, HissinN, HasaneinJ, Gam Ze LetovaY, et al.Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care, 2017; 40: 332–337.
9.
ForsterDA, MoorheadAM, JacobsSE, DavisPG, WalkerSP, McEganKM, et al.Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial. Lancet, 2017; 389: 2204–2213.
10.
ReynaudQ, Poupon-BourdyS, RabilloudM, Al MuftiL, Rousset JablonskiC, LemonnierL, et al.Pregnancy outcome in women with cystic fibrosis-related diabetes. Acta Obstet Gynecol Scand, 2017; 96: 1223–1227.
11.
Kallas-KoemanMM, KongJM, KlinkeJA, ButaliaS, LodhaAK, LimKI, DuanQM, DonovanLE. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia, 2014; 57: 681–689.
12.
RowanJA, HagueWM, GaoW, BattinMR, Moore MP; MiG TrialInvestigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med, 2008; 358: 2003–2015.
13.
Camelo CastilloW, BoggessK, SturmerT, BrookhartMA, BenjaminDKJr., Jonsson FunkM. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr, 2015; 169: 452–458.
